PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-58.66%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-57.94%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-108.34%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-113.57%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-105.56%
Negative net income growth while 6247.T stands at 18.89%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-105.56%
Negative EPS growth while 6247.T is at 18.91%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-105.56%
Negative diluted EPS growth while 6247.T is at 18.91%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
18.70%
10Y revenue/share CAGR at 50-75% of 6247.T's 29.85%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
90.15%
5Y revenue/share CAGR above 1.5x 6247.T's 16.56%. David Dodd would look for consistent product or market expansions fueling outperformance.
18.56%
Positive 3Y CAGR while 6247.T is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
90.57%
Positive 10Y CAGR while 6247.T is negative. John Neff might see a substantial advantage in bottom-line trajectory.
77.57%
Positive 5Y CAGR while 6247.T is negative. John Neff might view this as a strong mid-term relative advantage.
76.53%
Positive short-term CAGR while 6247.T is negative. John Neff would see a clear advantage in near-term profit trajectory.
406.76%
10Y equity/share CAGR above 1.5x 6247.T's 42.94%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
64.03%
5Y equity/share CAGR above 1.5x 6247.T's 20.39%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
17.57%
3Y equity/share CAGR above 1.5x 6247.T's 8.50%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-5.79%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-7.37%
Inventory is declining while 6247.T stands at 14.38%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-6.91%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
0.44%
Positive BV/share change while 6247.T is negative. John Neff sees a clear edge over a competitor losing equity.
-17.47%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-19.85%
Our R&D shrinks while 6247.T invests at 38.10%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
2.44%
SG&A growth well above 6247.T's 0.17%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.